NBIX holder plans sale of 4,367 common shares

Neurocrine Biosciences (NBIX) reports that an affiliate through Morgan Stanley Smith Barney LLC’s Executive Financial Services plans to sell 4,367 shares of common stock on 07/10/2026, in connection with an Exercise of Stock Options for cash.

Rhea-AI Filing Summary

Neurocrine Biosciences (NBIX) reports that an affiliate through Morgan Stanley Smith Barney LLC’s Executive Financial Services plans to sell 4,367 shares of common stock on 07/10/2026, in connection with an Exercise of Stock Options for cash. The planned sale reflects an indicated value of 788,461.85. In the prior three months, Ingrid Delaet completed multiple Rule 10b5-1 sales of NBIX common stock, including 8,433 shares on 07/09/2026 for 1,507,134.80 and additional sales on 07/08/2026, 07/07/2026, and 05/29/2026.

Insights

Equity Capital Markets Analyst

Planned NBIX insider sales continue under a Rule 10b5-1 trading plan.

The filing describes a plan to sell 4,367 shares of NBIX common stock tied to an Exercise of Stock Options, with an indicated value of 788,461.85. This is a registration for potential resale, not a new share issuance by the company.

It also lists recent Rule 10b5-1 transactions by Ingrid Delaet, including 8,433 shares on 07/09/2026 for 1,507,134.80, plus 2,737 shares on 07/08/2026, 3,401 shares on 07/07/2026, and 2,261 shares on 05/29/2026. Because these are pre-arranged plan sales, they are typically viewed as routine liquidity rather than discretionary trading.

Key Figures

Shares to be sold: 4,367 shares Indicated value of planned sale: 788,461.85 10b5-1 sale on 07/09/2026: 8,433 shares; 1,507,134.80 +3 more

6 metrics

Shares to be sold 4,367 shares Common stock registered for potential sale on 07/10/2026

Indicated value of planned sale 788,461.85 Value associated with 4,367 NBIX common shares to be sold

10b5-1 sale on 07/09/2026 8,433 shares; 1,507,134.80 NBIX common stock sold by Ingrid Delaet under Rule 10b5-1

10b5-1 sale on 07/08/2026 2,737 shares; 488,672.19 NBIX common stock sold by Ingrid Delaet under Rule 10b5-1

10b5-1 sale on 07/07/2026 3,401 shares; 607,305.01 NBIX common stock sold by Ingrid Delaet under Rule 10b5-1

10b5-1 sale on 05/29/2026 2,261 shares; 354,321.31 NBIX common stock sold by Ingrid Delaet under Rule 10b5-1

Key Terms

Form 144, Exercise of Stock Options, 10b5-1 Sales, Executive Financial Services

4 terms

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Exercise of Stock Options financial

"Common | 07/10/2026 | Exercise of Stock Options | Issuer"

10b5-1 Sales regulatory

"10b5-1 Sales for INGRID DELAET 6027 Edgewood Bend Court"

10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.

Executive Financial Services financial

"Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/10/2026 - 04:39 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001965808
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	NEUROCRINE BIOSCIENCES, INC.
SEC File Number	000-22705
Address of Issuer	6027 Edgewood Bend Court San Diego CALIFORNIA 92130
Phone	8586177600
Name of Person for Whose Account the Securities are To Be Sold	INGRID DELAET
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	4367	788461.85	100549983	07/10/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/10/2026	Exercise of Stock Options	Issuer			4367	07/10/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for INGRID DELAET 6027 Edgewood Bend Court San Diego CA 92130	Common	07/09/2026	8433	1507134.80
10b5-1 Sales for INGRID DELAET 6027 Edgewood Bend Court San Diego CA 92130	Common	07/08/2026	2737	488672.19
10b5-1 Sales for INGRID DELAET 6027 Edgewood Bend Court San Diego CA 92130	Common	07/07/2026	3401	607305.01
10b5-1 Sales for INGRID DELAET 6027 Edgewood Bend Court San Diego CA 92130	Common	05/29/2026	2261	354321.31

144: Remarks and Signature

Remarks
Date of Notice	07/10/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	02/27/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Ingrid Delaet
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)